2022
DOI: 10.21037/tau-22-176
|View full text |Cite
|
Sign up to set email alerts
|

A step forward toward establishing a novel preclinical porcine model to study ischemia/reperfusion-induced acute and chronic kidney injures

Abstract: Cite this article as: Zhou X. A step forward toward establishing a novel preclinical porcine model to study ischemia/ reperfusion-induced acute and chronic kidney injures. Transl

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…An animal model closely mimicking the clinical setting is important to understanding pathophysiology and testing therapeutic approaches. Although pigs are more similar to humans in physical size, physiology and immunology than rodents (Packialakshmi et al, 2020;Zhou, 2022), rodents are easy to handle, quickly reproduce and have contributed significantly to deciphering pathophysiology and developing novel therapies. As such, a majority of tourniquet-induced lower limb ischemia/ reperfusion (TILLIR) injury in the literature has been produced in rodents, and a variety of therapies have been tested using rodent models (Klausner et al, 1989;Adachi et al, 2006;Hsu et al, 2012;Mansour et al, 2014;Kao et al, 2015a;Kao et al, 2015b;Karahan et al, 2016;Onody et al, 2016;Foster et al, 2017;Shih et al, 2018;İnce et al, 2019).…”
Section: Figurementioning
confidence: 99%
“…An animal model closely mimicking the clinical setting is important to understanding pathophysiology and testing therapeutic approaches. Although pigs are more similar to humans in physical size, physiology and immunology than rodents (Packialakshmi et al, 2020;Zhou, 2022), rodents are easy to handle, quickly reproduce and have contributed significantly to deciphering pathophysiology and developing novel therapies. As such, a majority of tourniquet-induced lower limb ischemia/ reperfusion (TILLIR) injury in the literature has been produced in rodents, and a variety of therapies have been tested using rodent models (Klausner et al, 1989;Adachi et al, 2006;Hsu et al, 2012;Mansour et al, 2014;Kao et al, 2015a;Kao et al, 2015b;Karahan et al, 2016;Onody et al, 2016;Foster et al, 2017;Shih et al, 2018;İnce et al, 2019).…”
Section: Figurementioning
confidence: 99%